COMPASS Pathways PLC ADR (CMPS) Social Stream



COMPASS Pathways PLC ADR (CMPS): $16.96

-0.41 (-2.36%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

COMPASS Pathways plc (CMPS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering COMPASS Pathways plc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 7 $117 $50 $78.5 $14.18 453.6%
2021-11-10 7 $117 $63 $82.833 $14.18 484.15%
2021-12-14 7 $120 $63 $86.166 $14.18 507.66%
2022-02-28 7 $120 $58 $82.166 $14.18 479.45%

Over the past 111 days, CMPS's average upside potential has been 298.11%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-09 7 117 50 78.500 36.00 118.06%
2021-11-10 7 117 63 82.833 33.50 147.26%
2021-11-22 7 120 63 86.166 30.23 185.03%
2022-01-20 7 120 58 82.166 16.30 404.09%
2022-02-28 7 120 58 82.166 14.44 469.02%

CMPS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 7 0 0 0 0 7

The Trend in the Broker Recommendations


CMPS's average broker recommendation rating improved by 0 over the prior 92 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, COMPASS Pathways plc's upside potential (average analyst target price relative to current price) is higher than 385.3% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, COMPASS Pathways plc's average analyst price target is greater than 387.26% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, COMPASS Pathways plc's number of analysts covering the stock is higher than 345.48% of them.
  • COMPASS Pathways plc's variance in analysts' estimates is lower than -222.39% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to COMPASS Pathways plc are CLVR, CLSD, and CLNN.

Is CMPS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.34 seconds.